MY141374A - Water soluble camptothecin derivatives - Google Patents
Water soluble camptothecin derivativesInfo
- Publication number
- MY141374A MY141374A MYPI94001039A MYPI9401039A MY141374A MY 141374 A MY141374 A MY 141374A MY PI94001039 A MYPI94001039 A MY PI94001039A MY PI9401039 A MYPI9401039 A MY PI9401039A MY 141374 A MY141374 A MY 141374A
- Authority
- MY
- Malaysia
- Prior art keywords
- lower alkyl
- amino
- water soluble
- camptothecin derivatives
- methylpyrrolyl
- Prior art date
Links
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical class C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 title abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract 2
- -1 AMINO Chemical class 0.000 abstract 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- CZZYITDELCSZES-UHFFFAOYSA-N diphenylmethane Chemical group C=1C=CC=CC=1CC1=CC=CC=C1 CZZYITDELCSZES-UHFFFAOYSA-N 0.000 abstract 1
- 239000003534 dna topoisomerase inhibitor Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical class [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 229940044693 topoisomerase inhibitor Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5458593A | 1993-04-29 | 1993-04-29 | |
| US8104293A | 1993-06-22 | 1993-06-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY141374A true MY141374A (en) | 2010-04-16 |
Family
ID=26733234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI94001039A MY141374A (en) | 1993-04-29 | 1994-04-27 | Water soluble camptothecin derivatives |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0696285A1 (is) |
| JP (1) | JPH08509740A (is) |
| AP (1) | AP9400638A0 (is) |
| AU (1) | AU6777194A (is) |
| CA (1) | CA2161681A1 (is) |
| IL (1) | IL109470A0 (is) |
| IS (1) | IS4152A (is) |
| MY (1) | MY141374A (is) |
| PE (1) | PE52894A1 (is) |
| WO (1) | WO1994025466A1 (is) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6504029B1 (en) * | 1995-04-10 | 2003-01-07 | Daiichi Pharmaceutical Co., Ltd. | Condensed-hexacyclic compounds and a process therefor |
| US5663177A (en) * | 1995-05-31 | 1997-09-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
| SG88737A1 (en) * | 1996-10-30 | 2002-05-21 | Tanabe Seiyaku Co | S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
| US6559309B2 (en) | 1996-11-01 | 2003-05-06 | Osi Pharmaceuticals, Inc. | Preparation of a camptothecin derivative by intramolecular cyclisation |
| US6046209A (en) * | 1997-05-27 | 2000-04-04 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
| IN189180B (is) * | 1997-07-09 | 2003-01-04 | Chong Kun Dang Corp | |
| US6858598B1 (en) | 1998-12-23 | 2005-02-22 | G. D. Searle & Co. | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| US6288072B1 (en) * | 1999-12-29 | 2001-09-11 | Monroe E. Wall | Camptothecin β-alanine esters with topoisomerase I inhibition |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165346T3 (es) * | 1989-09-15 | 2002-03-16 | Res Triangle Inst | Analogos de 10,11-metilendioxi-20(rs)-camptotecina y 10,11-metilendioxi-20(s)-camptotecina. |
| DK0540099T3 (da) * | 1991-10-29 | 1996-06-17 | Glaxo Wellcome Inc | Vandopløselige camptothecinderivater |
| EP0556585A3 (en) * | 1992-01-24 | 1993-09-01 | Takeda Chemical Industries, Ltd. | Condensed camptothecin derivatives their production and use as antitumor agents |
-
1994
- 1994-04-25 IS IS4152A patent/IS4152A/is unknown
- 1994-04-27 MY MYPI94001039A patent/MY141374A/en unknown
- 1994-04-27 PE PE1994241061A patent/PE52894A1/es not_active Application Discontinuation
- 1994-04-28 AU AU67771/94A patent/AU6777194A/en not_active Abandoned
- 1994-04-28 IL IL10947094A patent/IL109470A0/xx unknown
- 1994-04-28 WO PCT/US1994/004681 patent/WO1994025466A1/en not_active Ceased
- 1994-04-28 JP JP6524540A patent/JPH08509740A/ja active Pending
- 1994-04-28 EP EP94915931A patent/EP0696285A1/en not_active Withdrawn
- 1994-04-28 AP APAP/P/1994/000638A patent/AP9400638A0/en unknown
- 1994-04-28 CA CA002161681A patent/CA2161681A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL109470A0 (en) | 1994-07-31 |
| WO1994025466A1 (en) | 1994-11-10 |
| CA2161681A1 (en) | 1994-11-10 |
| JPH08509740A (ja) | 1996-10-15 |
| AU6777194A (en) | 1994-11-21 |
| IS4152A (is) | 1994-10-30 |
| EP0696285A1 (en) | 1996-02-14 |
| PE52894A1 (es) | 1995-01-06 |
| AP9400638A0 (en) | 1995-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY108261A (en) | Water soluble camptothecin derivatives | |
| AU583439B2 (en) | Prodrugs of rapamycin | |
| MY109296A (en) | Water soluble camptothecin derivatives | |
| TR199900481T2 (xx) | �ndazol t�revleri; fosfodiesteraz tip IV inhibit�rleri olarak kullan�mlar�. | |
| EP0409406A3 (en) | Aryl-substituted amine derivatives useful in cancer therapy | |
| MY116952A (en) | 4 substituted 2-carboxy-tetrahydroquinoline derivatives, pharmaceutical compositions comprising them and process for their preparation | |
| UA35562C2 (uk) | Похідні 7-ізоіндолінілхінолону і 7-ізоіндолінілнафтирідону | |
| ZA882282B (en) | Amino-5,6,7,8-tetrahydronaphtho(2,3-b)furan derivatives the processes for preparing them and the pharmaceutical compositions which contain them | |
| AP9400638A0 (en) | Water soluble derivatives of camptothecin. | |
| MY103905A (en) | Aminoalkoxyphenyl derivatives, process of preparation and compositions containing the same. | |
| NZ335252A (en) | Substituted 3-thia-1,2,3,4-tetrahydrocarbazole, 6,7,8,9-tetrahydropyrido[1,2-a]indole, 4,5-dihydro-thiopyrano[3,4-b]indole, pyrano[3,4-b]indole or beta-carbolinyl derivatives | |
| GB9119983D0 (en) | Dihydropyridine derivatives useful in antitumor therapy | |
| NZ212231A (en) | Cephalosporin derivatives; intermediates and pharmaceutical compositions | |
| UA41281C2 (uk) | Тіоксантенонові сполуки, фармацевтична композиція на їх основі з протипухлинною активністю | |
| EP0315434A3 (en) | Pyridoxal hydrazone derivatives their production and use and pharmaceutical compositions containing the same | |
| JO1274B1 (en) | Pyridine derivatives | |
| MY103515A (en) | Ergolinyl heterocycles | |
| CA2070120A1 (en) | Thioxanthenone antitumor agents | |
| SE0000537D0 (sv) | Use of a compound for preparing a drug | |
| DE60010665D1 (de) | Mittel zur verwendung in der transplantation | |
| MY103577A (en) | New aminoacylates of glycerol acetal | |
| NZ222973A (en) | Substituted piperidine and azepine derivatives and pharmaceutical compositions | |
| MX9806036A (es) | Compuestos para inhibir tumores en el colon. |